Aug 6 |
Prediction: This Will Be the Best Pharmaceutical Stock to Own Over the Next 10 Years
|
Aug 6 |
Novo and Lilly Need a Profit Beat to Take Back Market Momentum
|
Aug 6 |
Prediction: These Could Be the Best-Performing Value Stocks Through 2030
|
Aug 5 |
FDA indicates Lilly, Novo weight-loss drug shortages easing
|
Aug 5 |
Eli Lilly's Zepbound Challenges Novo Nordisk's Wegovy Amid Supply Issues
|
Aug 5 |
Will These 5 Medical Stocks Surpass Q2 Earnings Forecasts?
|
Aug 5 |
Should You Buy, Sell or Hold Lilly (LLY) Ahead of Q2 Earnings?
|
Aug 5 |
Lilly (LLY) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
|
Aug 5 |
10 Imploding Stocks Cost Investors A Staggering $2 Trillion
|
Aug 5 |
Zepbound, Mounjaro back in supply as Lilly resolves shortage
|